Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6631)	5/10/1999 10:07:00 PM
From: VLAD	Respond to of 7041

Certainly a damning article by thestreet.com. The part that I think was a real knife in the heart of Zonagen was: <<But rarely do drugs get approved after they get a non-approvable letter. "It's just a disaster. I think even here, the stock is a short," says one consultant for the company, speaking on the condition of anonymity.>> It really doesn't get much worse than that IMHO. When a consultant for the company says something like that you can rest be assured that this is only the beginning of the end.